TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36250951

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) patients
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26
Study: 34747186

Group type: EXPERIMENTAL
Intervention: Amulet
Number of subjects: 221

Group type: COMPARATOR
Intervention: Watchman
Number of subjects: 221
Study: 33989320

Group type: EXPERIMENTAL
Intervention: Writing exercise focusing on body functionality of 'Anne'
Number of subjects: 98

Group type: COMPARATOR
Intervention: Active control group (describing 'Anne's' home)
Number of subjects: 98
Study: 33106168

Group type: COMPARATOR
Intervention: Placebo (288 mg of rice protein, 109.3 mg microcrystalline cellulose)
Number of subjects: 0
Study: 34004154

Group type: EXPERIMENTAL
Intervention: Implementation of the HOME-CoV rule during the interventional period
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Observational period without the HOME-CoV rule
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Patients treated at home during the interventional period
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Patients treated at home during the observational period
Number of subjects: 3000
Study: 35246395

Group type: EXPERIMENTAL
Intervention: Tianjiang Xueshuantong Wan pills
Number of subjects: 72

Group type: COMPARATOR
Intervention: rt‐PA intravenous thrombolysis
Number of subjects: 72
Study: 33483908

Group type: EXPERIMENTAL
Intervention: Safety skills training
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Safety inoculation training
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Positive atmosphere for safety learning
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Active learning techniques
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Core components overall
Number of subjects: 229
Study: 32482392

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 56

Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC)
Number of subjects: 56
Study: 616861719

Group type: EXPERIMENTAL
Intervention: 100 mg immunologically active gluten/d
Number of subjects: 715

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Gluten consumption pattern
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: HLA risk group and gluten consumption pattern
Number of subjects: 715
Study: 36870589

Group type: EXPERIMENTAL
Intervention: WFG-LASIK
Number of subjects: 100

Group type: COMPARATOR
Intervention: WFO-LASIK
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: WFG-LASIK or WFO-LASIK
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preferred eye
Number of subjects: 100
Study: 33262048

Group type: EXPERIMENTAL
Intervention: SuperPath approach
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional posterolateral approach
Number of subjects: 96
Study: 35463674

Group type: EXPERIMENTAL
Intervention: All-inclusive and hierarchical rehabilitation nursing model combined with acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine rehabilitation nursing
Number of subjects: 80
Study: 34158569

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: No placebo (control group)
Number of subjects: 160
Study: 34927683

Group type: EXPERIMENTAL
Intervention: Bolus nasogastric feeding
Number of subjects: 189

Group type: COMPARATOR
Intervention: Continuous nasogastric feeding
Number of subjects: 189
Study: 33151321

Group type: EXPERIMENTAL
Intervention: 5-day simulation-based cataract surgical training course
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard surgical training only (Control)
Number of subjects: 50
Study: 32191586

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 units per day)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg per day)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Vitamin E + C for 90 days
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control
Number of subjects: 91
Study: 35105495

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: BCG + HBV group
Number of subjects: 185

Group type: COMPARATOR
Intervention: HBV vaccine
Number of subjects: 185
Study: 33771603

Group type: EXPERIMENTAL
Intervention: High-density SNP microarrays
Number of subjects: 180
Study: 35123322

Group type: EXPERIMENTAL
Intervention: 4G-beta-D-Galactosylsucrose (LS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34337003

Group type: COMPARATOR
Intervention: Negative control (G2)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation (G3)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: CPP‐ACFP paste (G4)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation followed by CPP‐ACFP paste application (G5)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: CPP‐ACFP paste application followed by CO2 laser irradiation (G6)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Positive control (G1)
Number of subjects: 84
Study: 34239050

Group type: EXPERIMENTAL
Intervention: MyBP
Number of subjects: 62

Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 62
Study: 32282308

Group type: EXPERIMENTAL
Intervention: Withania somnifera extract, 1g/day, n = 22
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo, n = 18
Number of subjects: 40
Study: 32062741

Group type: EXPERIMENTAL
Intervention: ddPCR WT1 assay (0 copies/μl)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: ddPCR WT1 assay (1 to 15.2 copies/μl)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: ddPCR WT1 assay
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: ddPCR WT1 results
Number of subjects: 49
Study: 35645564

Group type: EXPERIMENTAL
Intervention: Congruence Couple Therapy (CCT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Treatment‐as‐Usual (TAU)
Number of subjects: 38
Study: 32168168

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) delivered by women to their male partners
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 1514

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 1514
Study: 35982587

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (8 sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 33950234

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment for 1 year (n=19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo treatment for 1 year (n=18)
Number of subjects: 37
Study: 32839856

Group type: EXPERIMENTAL
Intervention: 3D-printable drilling protection device
Number of subjects: 0

Group type: COMPARATOR
Intervention: No device
Number of subjects: 0
Study: 32576237

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 100
Study: 35148428

Group type: EXPERIMENTAL
Intervention: Special communication application used by the experimental group.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no application used).
Number of subjects: 46
Study: 33657562

Group type: EXPERIMENTAL
Intervention: Exergaming 2×/week for 8 weeks
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Exergaming 3×/week for 8 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (0× exergaming)
Number of subjects: 160
Study: 35236649

Group type: EXPERIMENTAL
Intervention: Jiawei Qingxuan Jiangya Decoction
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (benazepril hydrochloride tablets)
Number of subjects: 400
Study: 33849341

Group type: EXPERIMENTAL
Intervention: Vascular-targeted photodynamic therapy (PDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active surveillance (AS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salvage radical prostatectomy (sRP) after focal therapy (FT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salvage radical prostatectomy (sRP) after radiation therapy (RT)
Number of subjects: 0
Study: 34229502

Group type: EXPERIMENTAL
Intervention: Compression group (Group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Medical treatment group (Group 2)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sclerotherapy group (Group 3)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 32673678

Group type: EXPERIMENTAL
Intervention: Various prevention strategies for pelvic organ prolapse (41 strategies identified)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Various prevention strategies for urinary tract infection (58 strategies identified)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Various prevention strategies for overactive bladder (28 strategies identified)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Various prevention strategies for stress urinary incontinence (34 strategies identified)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Various prevention strategies for interstitial cystitis (79 strategies identified)
Number of subjects: 1000
Study: 34077510

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 616
Study: 33084773

Group type: EXPERIMENTAL
Intervention: Oral cryotherapy during the infusion of 5-FU
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiological serum mouthwash
Number of subjects: 60
Study: 33021877

Group type: EXPERIMENTAL
Intervention: Social and Behaviour Change Communication intervention (weekly radio programming, listening and discussion groups, community engagement)
Number of subjects: 1440

Group type: EXPERIMENTAL
Intervention: Social and Behaviour Change Communication intervention
Number of subjects: 1440
Study: 33098800

Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic blood pressure goal of less than 120 mm Hg)
Number of subjects: 2921

Group type: COMPARATOR
Intervention: Standard treatment (systolic blood pressure goal of less than 140 mm Hg)
Number of subjects: 2921
Study: 35829925

Group type: COMPARATOR
Intervention: 10 mg tablet
Number of subjects: 80

Group type: COMPARATOR
Intervention: 50 mg tablet
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.72% oral powder formulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: 7.2% oral powder formulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral powder formulations with different vehicles (apple juice, apple sauce, yogurt)
Number of subjects: 80
Study: 34162353

Group type: EXPERIMENTAL
Intervention: In Balance intervention (14-week, low-cost group fall prevention intervention including educational component and physical exercises based on Tai Chi principles)
Number of subjects: 256

Group type: COMPARATOR
Intervention: General written physical activity recommendations (control group)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: In Balance intervention
Number of subjects: 256
Study: 35537578

Group type: EXPERIMENTAL
Intervention: Hypofractionated RT (68 Gy/25 fractions)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional RT (78 Gy/39 fractions)
Number of subjects: 96
Study: 34638151

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose bemiparin (115 IU/kg daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard prophylactic dose (bemiparin 3,500 IU daily)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose bemiparin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard prophylactic dose
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 33646147

Group type: EXPERIMENTAL
Intervention: Genetically predicted CSF Aβ
Number of subjects: 3146

Group type: EXPERIMENTAL
Intervention: Genetically predicted CSF p-tau
Number of subjects: 3146

Group type: EXPERIMENTAL
Intervention: Genetically predicted CSF t-tau
Number of subjects: 3146
Study: 32325958

Group type: EXPERIMENTAL
Intervention: Modified instructions
Number of subjects: 171

Group type: COMPARATOR
Intervention: Standard manufacturer instructions
Number of subjects: 171
Study: 35873779

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Bimanual Training (RBMT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional Therapy (CT)
Number of subjects: 19
Study: 33833378

Group type: EXPERIMENTAL
Intervention: MRI before starting AS
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: MRI after being on AS
Number of subjects: 1286

Group type: COMPARATOR
Intervention: No MRI
Number of subjects: 1286
Study: 32228379

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saxagliptin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 33675448

Group type: EXPERIMENTAL
Intervention: Pocket compression device
Number of subjects: 108

Group type: COMPARATOR
Intervention: Elastic adhesive tape
Number of subjects: 108
Study: 34295702

Group type: EXPERIMENTAL
Intervention: CCTA + dynamic CT‐MPI
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: CCTA + CT‐FFR
Number of subjects: 412
Study: 32738875

Group type: EXPERIMENTAL
Intervention: Topical citicoline and vitamin B12 (Cit‐B12) 3 times daily for 18 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo 3 times daily for 18 months
Number of subjects: 30
Study: 35450755

Group type: EXPERIMENTAL
Intervention: Porcine-derived fibrin sealant (PFS) with dural sutures
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sutures alone
Number of subjects: 200
Study: 32649851

Group type: EXPERIMENTAL
Intervention: Jin Shin Jyutsu (JSJ) Self-Help educational intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 41
Study: 32396564

Group type: EXPERIMENTAL
Intervention: €15 voucher for a supermarket with the questionnaire
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group (only received the questionnaire)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Intervention group (males)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Intervention group (females)
Number of subjects: 262
Study: 34898320

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (16 mg IV daily for 5 days followed by 8 mg daily for 5 days)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Low-dose dexamethasone (6 mg IV daily for 10 days)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone
Number of subjects: 98

Group type: COMPARATOR
Intervention: Low-dose dexamethasone
Number of subjects: 98
Study: 33611380

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online discussion forum
Number of subjects: 0
Study: 36375083

Group type: EXPERIMENTAL
Intervention: Transurethral irrigation with 0.01% lidocaine (100 mg in 1 L normal saline)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Normal saline irrigation
Number of subjects: 94
Study: 35503346

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure with telemonitoring (n=1223)
Number of subjects: 2441

Group type: COMPARATOR
Intervention: Usual antenatal care alone (n=1218)
Number of subjects: 2441
Study: 34895216

Group type: EXPERIMENTAL
Intervention: ALERT intervention (multi-faceted health care system intervention including end-user participation, competency-based training, quality improvement, and empowerment of maternity unit leaders)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ALERT intervention components
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ALERT intervention
Number of subjects: 16
Study: 36036920

Group type: EXPERIMENTAL
Intervention: eCDS with the DEP
Number of subjects: 941

Group type: COMPARATOR
Intervention: eCDS without the DEP (Control)
Number of subjects: 941
Study: 34266897

Group type: EXPERIMENTAL
Intervention: Metyrapone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 35291425

Group type: EXPERIMENTAL
Intervention: GL‐HOSVD denoising algorithm in DWI
Number of subjects: 210

Group type: COMPARATOR
Intervention: Conventional DWI (control group)
Number of subjects: 210
Study: 32746862

Group type: EXPERIMENTAL
Intervention: Complex intervention for adolescents with chronic conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reasons for participation
Number of subjects: 0
Study: 35417873

Group type: EXPERIMENTAL
Intervention: NASH and class I obesity with comorbid COPD (Group 2)
Number of subjects: 49
Study: 33185618

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 33316444

Group type: EXPERIMENTAL
Intervention: Ceramic-on-ceramic (CoC) THA
Number of subjects: 116

Group type: COMPARATOR
Intervention: Metal-on-conventional polyethylene (MoPc) THA
Number of subjects: 116
Study: 35184887

Group type: EXPERIMENTAL
Intervention: Gastric juice + brushing
Number of subjects: 5

Group type: COMPARATOR
Intervention: Artificial saliva + brushing
Number of subjects: 5
Study: 34184772

Group type: EXPERIMENTAL
Intervention: 10 mg litoxetine
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 20 mg litoxetine
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 40 mg litoxetine
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 30 mg litoxetine
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 32825977

Group type: EXPERIMENTAL
Intervention: Fateh technique (16-min soft tissue manipulation for four weekly sessions)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Home exercise (two daily exercises for four weeks)
Number of subjects: 52
Study: 33690238

Group type: EXPERIMENTAL
Intervention: Triple therapy with tamsulosin, dutasteride, and imidafenacin (TDI)
Number of subjects: 0
Study: 32937232

Group type: EXPERIMENTAL
Intervention: Test dentifrice (with cocamidopropyl betaine) with an orange juice (OJ) rinse
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Test dentifrice (with cocamidopropyl betaine) with deionized (DI) water rinse
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparator dentifrice (with sodium lauryl sulphate and tetrasodium pyrophosphate) with an OJ rinse
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Test dentifrice (with cocamidopropyl betaine) with an OJ rinse
Number of subjects: 18
Study: 34041604

Group type: EXPERIMENTAL
Intervention: In situ production of organic materials
Number of subjects: 124

Group type: COMPARATOR
Intervention: Petroleum-originated contaminants
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Bacterial inputs
Number of subjects: 124

Group type: COMPARATOR
Intervention: Allochthonous and petroleum-based inputs
Number of subjects: 124
Study: 32087818

Group type: EXPERIMENTAL
Intervention: Nerinetide (2.6 mg/kg, max 270 mg)
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Nerinetide
Number of subjects: 1105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Nerinetide and Placebo
Number of subjects: 1105
Study: 34296810

Group type: EXPERIMENTAL
Intervention: Influenza testing via PCR
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: RSV testing via PCR
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: Household transmission of influenza
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: Overall PCR-confirmed influenza incidence
Number of subjects: 1684
Study: 32493475

Group type: EXPERIMENTAL
Intervention: Melatonin (2 mg orally before bedtime for 12 weeks)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo (identical looking, orally before bedtime for 12 weeks)
Number of subjects: 450
Study: 34699040

Group type: EXPERIMENTAL
Intervention: Routine Standard Treatment with Vitamin C
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Routine Standard Treatment with Alpha Lipoic Acid (ALA)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Routine Standard Treatment with Vitamin C and Alpha Lipoic Acid (ALA)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Routine Standard Treatment (RST)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 35603596

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 32970395

Group type: EXPERIMENTAL
Intervention: EDS‐FLU 372 μg
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: EDS‐FLU 186 μg
Number of subjects: 482

Group type: COMPARATOR
Intervention: Standard nasal steroid sprays
Number of subjects: 482
Study: 32730284

Group type: EXPERIMENTAL
Intervention: Bayesian segmented regression model with informative prior distributions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Bayesian segmented regression model with minimally informative prior distributions
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Genotype P4285HX
Number of subjects: 25
Study: 35429307

Group type: EXPERIMENTAL
Intervention: Economic empowerment intervention (matched savings accounts, mentorship, financial management, business development training)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Economic empowerment intervention
Number of subjects: 702

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 702
Study: 34411297

Group type: EXPERIMENTAL
Intervention: Clinical treatment network analysis
Number of subjects: 100000
Study: 32571560

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOA)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKA)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 900
Study: 33588897

Group type: EXPERIMENTAL
Intervention: C1‐INH(SC) 60 IU/kg
Number of subjects: 126
Study: 32039990

Group type: COMPARATOR
Intervention: apoB truncation
Number of subjects: 57973

Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 57973
Study: 36409539

Group type: EXPERIMENTAL
Intervention: Keenoa
Number of subjects: 136

Group type: COMPARATOR
Intervention: ASA24
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Keenoa and ASA24
Number of subjects: 136
Study: 32068510

Group type: EXPERIMENTAL
Intervention: alfaxalone (5 mg/kg) and midazolam (0.5 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: dexmedetomidine (0.05 mg/kg) and midazolam (0.5 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: flumazenil (0.05 mg/kg) alone or in combination with atipamezole (0.5 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: plethysmography
Number of subjects: 12